Therapies for Inherited Neuropathies is a registered 501(C)(3) health organization, focused on improving the lives of people with Charcot-Marie-Tooth disease
Solutions Now
Physical therapy videos and articles dedicated to expert insights on the latest treatment options, and practical therapies designed to improve mobility, reduce symptoms, and enhance daily life.
1:2500
CMT affects 1 in 2500 people, meaning more than three million people world-wide are affected with Charcot Marie Tooth (CMT)
2
Current treatment options are limited to bracing, and surgery in some cases
130,000+
Those affected in the US population. CMT impacts those of all ages, sex, faith or race
Proud of the company we keep
Our Board members and Advisors have made a commitment to contribute their expert skills to a common goal: Improving the lives of members of the CMT community

Steve O’Donnell
Founder & CEO

Tom Haslach
Board of Directors

Steve O’Connell
Board of Directors

Jimmy Reyes
Board of Directors

Bob Shaffer
Board of Directors

David Todd
Board of Directors

Mark Scheideler, Ph.D.
Chief Science Officer

Mario Bortolozzi, Ph.D.
Advisory Board

Scott Heinlein
Advisory Board

Jon Lai, Ph.D.
Advisory Board

Rudolf Martini, Ph.D.
Advisory Board

Wendy Quitasol
Advisory Board

E. Richard Stanley, Ph.D.
Advisory Board

Mike Studer, P.T., M.H.S.
Advisory Board

Therapies for Inherited Neuropathies
PO Box 5630 Baltimore, MD 21210
© 2025 Therapies for Inherited Neuropathies. All rights reserved. Website by CWD.